|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02315 BIOCYTOGEN-B
Nominal 
63.500 +3.950 (+6.633%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,365,842 | 1.212% | 1,349,489 | 1,450,828 | 1,599,079 | 1,390,945 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 0 |
| Intangible Assets | 13,360 | -35.350% | 20,665 | 28,130 | 30,652 | 6,055 |
| Interests in Asso. & JCEs | 137,453 | -13.572% | 159,038 | 188,375 | 197,944 | 9,685 |
| Other Non-current Assets | 58,936 | -15.306% | 69,587 | 59,025 | 52,861 | 21,860 |
| 1,575,591 | -1.450% | 1,598,779 | 1,726,358 | 1,880,536 | 1,428,545 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 7,546 | 93.985% | 3,890 | 7,416 | 18,604 | 15,140 | |
| Trade Receivables | 300,310 | 30.792% | 229,608 | 142,384 | 107,682 | 103,089 | |
| Cash & Bank Balances | 1,552,556 | 303.830% | 384,458 | 399,607 | 610,882 | 466,445 | |
| Other Current Assets | 288,361 | 45.212% | 198,579 | 173,643 | 182,128 | 289,564 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 2,148,773 | 163.157% | 816,535 | 723,050 | 919,296 | 874,238 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 135,830 | 17.623% | 115,479 | 175,234 | 146,190 | 102,441 | ||
| S-T Debt & Leases | 227,361 | 0.604% | 225,995 | 203,199 | 171,603 | 26,897 | ||
| Other Current Liabilities | 567,115 | 193.175% | 193,439 | 199,183 | 288,253 | 317,221 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 930,306 | 73.917% | 534,913 | 577,616 | 606,046 | 446,559 | |||
| Net Current Assets | 1,218,467 | 332.660% | 281,622 | 145,434 | 313,250 | 427,679 | ||
| Total Assets Less Current Liabilities | 2,794,058 | 48.588% | 1,880,401 | 1,871,792 | 2,193,786 | 1,856,224 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 356,730 | 3.616% | 344,282 | 340,910 | 243,677 | 62,902 | |||
| Other Non-current Liabilities | 257,874 | -63.030% | 697,518 | 740,446 | 799,293 | 541,351 | |||
| 614,604 | -41.006% | 1,041,800 | 1,081,356 | 1,042,970 | 604,253 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 446,898 | 11.893% | 399,398 | 399,398 | 399,398 | 374,930 | ||||
| Reserves | 1,728,011 | 297.556% | 434,658 | 386,488 | 746,867 | 872,278 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 2,174,909 | 160.763% | 834,056 | 785,886 | 1,146,265 | 1,247,208 | ||||
| Non-controlling Interests | 4,545 | 0.000% | 4,545 | 4,550 | 4,551 | 4,763 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 2,179,454 | 159.892% | 838,601 | 790,436 | 1,150,816 | 1,251,971 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 12,458 | 8,838 | 52,575 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 173,199 |
| %Change | 416.365% |
| EPS / (LPS) | RMB 0.430 |
| NBV Per Share (¥) | RMB 4.867 |